VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
32 hedge funds and large institutions have $583K invested in Viracta Therapeutics, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
55% less capital invested
Capital invested by funds: $1.29M → $583K (-$709K)
Holders
32
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$21K | |
| 2 | +$17.1K | |
| 3 | +$15K | |
| 4 |
Jane Street
New York
|
+$8.92K |
| 5 |
Renaissance Technologies
New York
|
+$6.6K |
Top Sellers
| 1 | -$160K | |
| 2 | -$116K | |
| 3 | -$107K | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$76.9K |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$15.8K |